Actualités réglementaires

The UK Medicines and Healthcare products Regulatory Agency released a list of Field Safety Notices on 1 May 2026.

Milpharm Limited has found a discrepancy in the approved Patient Information Leaflet for its 2 mg Loperamide hydrochloride orodispersible tablets.

The UK Medicines and Healthcare products Regulatory Agency released a list of Field Safety Notices covering the period 4 to 8 May 2026.

The UK Medicines and Healthcare products Regulatory Agency (MHRA) released a list of Field Safety Notices issued between 27 April and 1 May 2026.

Fresenius Medical Care Deutschland GmbH identified an error in the Braille printing on the outer label of its product, as noted in an MHRA alert.

Using an IV infusion giving set instead of a blood transfusion set may cause serious patient harm.

The UK Medicines and Healthcare products Regulatory Agency released a list of Field Safety Notices covering the period 11‑15 May 2026.

Medline Industries and Kimal PLC have reported safety concerns with Namic Angiographic Control Syringes and White Star Off‑Handle Manifold devices, issuing field safety notices to UK hospitals.

The MHRA reports rare cases where the Allurion Gastric Balloon failed to transit, causing gastric outlet obstruction, small bowel obstruction, or gastric perforation.

Crescent Pharma Limited is recalling a batch of 2.5 mg Ramipril capsules due to a possible packaging error.

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has issued a list of field safety notices covering the period 25 to 29 May 2026.

Edwards reports mislabelled sensor cables on the ForeSight™ Oximeter Cable may cause swapped left/right StO2 values, risking misdiagnosis.